Literature DB >> 12896874

Heterogeneity of heparan sulfates in human lung.

Nicole C Smits1, Antoine A Robbesom, Elly M M Versteeg, Els M A van de Westerlo, P N Richard Dekhuijzen, Toin H van Kuppevelt.   

Abstract

Heparan sulfates (HS), a class of glycosaminoglycans, are long linear complex polysaccharides covalently attached to a protein core. The HS molecules are made up of repeating disaccharides onto which modification patterns are superimposed. This results in a large structural heterogeneity and forms the basis of specific interactions of HS toward a vast array of proteins, including growth factors and proteases. To study HS heterogeneity in the lung, we used phage display technology to select seven antibodies against human lung HS. Antibodies reacted with HS/heparin, but not with other glycosaminoglycans or polyanions. Sulfate groups were essential for antibody binding. The amino acid sequence of the antibodies was established, the complementarity determining region 3 of the heavy chain containing basic amino acids. The antibodies defined HS epitopes with a characteristic tissue distribution. Antibody EV3A1 primarily stained macrophages. Other antibodies primarily stained basement membranes, but with different preference toward type of basement membrane. Antibody EV3C3 was the only antibody which clearly reacted with bronchiolar epithelial cells. In human lung parenchyma, basic fibroblast growth factor and vascular endothelial growth factor were largely bound by HS. Some antibodies blocked a basic fibroblast growth factor-binding site of HS, and one antibody blocked a vascular endothelial growth factor-binding site of heparin. Taken together, these data suggest a specific role for HS epitopes in human lung. The antibodies obtained may be valuable tools to study HS in pulmonary diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12896874     DOI: 10.1165/rcmb.2003-0198OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  17 in total

Review 1.  Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection.

Authors:  Sean Gill; Thomas N Wight; Charles W Frevert
Journal:  Anat Rec (Hoboken)       Date:  2010-06       Impact factor: 2.064

Review 2.  Revascularization of decellularized lung scaffolds: principles and progress.

Authors:  Collin T Stabler; Shimon Lecht; Mark J Mondrinos; Ernesto Goulart; Philip Lazarovici; Peter I Lelkes
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-09-25       Impact factor: 5.464

3.  Characterization of the interaction between the chlamydial adhesin OmcB and the human host cell.

Authors:  Tim Fechtner; Sonja Stallmann; Katja Moelleken; Klaus L Meyer; Johannes H Hegemann
Journal:  J Bacteriol       Date:  2013-09-20       Impact factor: 3.490

Review 4.  Heparan Sulfate in the Developing, Healthy, and Injured Lung.

Authors:  Sarah M Haeger; Yimu Yang; Eric P Schmidt
Journal:  Am J Respir Cell Mol Biol       Date:  2016-07       Impact factor: 6.914

5.  Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfation.

Authors:  Minh Bao Huynh; Christophe Morin; Gilles Carpentier; Stephanie Garcia-Filipe; Sofia Talhas-Perret; Véronique Barbier-Chassefière; Toin H van Kuppevelt; Isabelle Martelly; Patricia Albanese; Dulce Papy-Garcia
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

6.  The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease.

Authors:  Nicole C Smits; Sindhulakshmi Kurup; Angelique L Rops; Gerdy B ten Dam; Leon F Massuger; Theo Hafmans; Jeremy E Turnbull; Dorothe Spillmann; Jin-ping Li; Stephen J Kennel; Jonathan S Wall; Nicholas W Shworak; P N Richard Dekhuijzen; Johan van der Vlag; Toin H van Kuppevelt
Journal:  J Biol Chem       Date:  2010-09-13       Impact factor: 5.157

7.  Identification of glycosaminoglycans in human airway secretions.

Authors:  Maria E Monzon; Susana M Casalino-Matsuda; Rosanna M Forteza
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09-29       Impact factor: 6.914

8.  Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.

Authors:  Hiroto Matsuoka; Thomas H Sisson; Teruaki Nishiuma; Richard H Simon
Journal:  Am J Respir Cell Mol Biol       Date:  2006-07-13       Impact factor: 6.914

9.  Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?

Authors:  Sophie M Thompson; Marilyn G Connell; Toin H van Kuppevelt; Ruoyan Xu; Jeremy E Turnbull; Paul D Losty; David G Fernig; Edwin C Jesudason
Journal:  BMC Dev Biol       Date:  2011-06-14       Impact factor: 1.978

10.  ScFv antibody-induced translocation of cell-surface heparan sulfate proteoglycan to endocytic vesicles: evidence for heparan sulfate epitope specificity and role of both syndecan and glypican.

Authors:  Anders Wittrup; Si-He Zhang; Gerdy B ten Dam; Toin H van Kuppevelt; Per Bengtson; Maria Johansson; Johanna Welch; Matthias Mörgelin; Mattias Belting
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.